WA developed drug candidate may help treat Alzheimer’s
A neuroprotective drug candidate being trialled in Western Australia for stroke may also be beneficial for treating Alzheimer’s disease. The...
Continue reading
This website may not work correctly in Internet Explorer. We recommend switching to a more secure modern web browser such as Microsoft Edge which is already installed on your computer.
A renowned Western Australian ophthalmologist who led the development of a revolutionary intervention to treat the sight stealing eye disease, glaucoma, has been awarded an inaugural Byron Kakulas Medal.
The medal, honouring the late distinguished neuropathologist Emeritus Professor Byron Kakulas AO, founding Director of WA’s Perron Institute, acknowledges people who have had a transformational impact on the health of Western Australians, whether through medical research, clinical practice, health policy, service delivery or community outreach.
The second of the two Byron Kakulas medals awarded went to the high achieving, highly energetic Perioperative Medicine Team, a collaboration between the Anaesthesia and Pain Medicine Department at Perth Children’s Hospital (PCH) and The University of Western Australia’s (UWA) Laboratory for Drug Delivery and Telethon Kids Institute.
Here at Perron Institute we’re bringing dedicated researchers and clinicians together to work on a brighter future for people living with neurological conditions.
Clinical trials are an essential tool in modern medicine. We rely on voluntary participants to take part in our studies and trials for new treatments and interventions to improve patient’s quality of life. We are currently recruiting participants for the following studies and trials:
With the support of our partners, Perron Institute is able to conduct major research into challenges in neurology.
Keep informed with our latest updates.
Stay up to date with our latest news and announcements.